메뉴 건너뛰기




Volumn 53, Issue 8, 2006, Pages 1467-1477

A spatiotemporal, patient individualized simulation model of solid tumor response to chemotherapy in vivo: The paradigm of glioblastoma multiforme treated by temozolomide

Author keywords

Cancer; Chemotherapy; Chemotherapy optimization; Glioblastoma multiforme; In silico oncology; Monte Carlo; Neovasculature; Patient individualized optimization; Simulation model; Temodal ; Temodar ; Temozolomide; Tumor growth

Indexed keywords

ALGORITHMS; CHEMOTHERAPY; COMPUTER SIMULATION; MEDICAL IMAGING; MONTE CARLO METHODS; ONCOLOGY; OPTIMIZATION; PATHOLOGY; TOXICITY; TUMORS;

EID: 33746622960     PISSN: 00189294     EISSN: None     Source Type: Journal    
DOI: 10.1109/TBME.2006.873761     Document Type: Article
Times cited : (51)

References (66)
  • 1
    • 0016791386 scopus 로고
    • Mathematic models for cancer chemotherapy: Pharmacokinetic and cell kinetic considerations
    • S. Chuang, "Mathematic models for cancer chemotherapy: pharmacokinetic and cell kinetic considerations," Cancer Chemother. Rep., vol. 59, no. 4, pp. 827-12, 1975.
    • (1975) Cancer Chemother. Rep. , vol.59 , Issue.4 , pp. 827-912
    • Chuang, S.1
  • 2
    • 0018939256 scopus 로고
    • Heuristic modeling of drug delivery to malignant brain tumors
    • V. A. Levin, C. S. Patlak, and H. D. Landahl, "Heuristic modeling of drug delivery to malignant brain tumors," J. Pharmacokinet. Biopharm., pp. 257-2968, 1980.
    • (1980) J. Pharmacokinet. Biopharm. , pp. 257-2968
    • Levin, V.A.1    Patlak, C.S.2    Landahl, H.D.3
  • 3
    • 0024327711 scopus 로고
    • Kinetic analysis of cell killing effect induced by cytosine arabinoside and cisplatin in relation to cell cycle phase specificity in human colon cancer and chinese hamster cells
    • S. Ozawa, Y. Sugiyama, J. Mitsuhashi, and M. Inaba, "Kinetic analysis of cell killing effect induced by cytosine arabinoside and cisplatin in relation to cell cycle phase specificity in human colon cancer and chinese hamster cells," Cancer Res., vol. 49, pp. 3823-3828, 1989.
    • (1989) Cancer Res. , vol.49 , pp. 3823-3828
    • Ozawa, S.1    Sugiyama, Y.2    Mitsuhashi, J.3    Inaba, M.4
  • 4
    • 0028483129 scopus 로고
    • Teaching cancer chemotherapy by means of a computer simulation
    • Y. Jean, J. De Traversay, and P. Lemieux, "Teaching cancer chemotherapy by means of a computer simulation," Int. J. Biomed. Comput., vol. 36, pp. 273-280, 1994.
    • (1994) Int. J. Biomed. Comput. , vol.36 , pp. 273-280
    • Jean, Y.1    De Traversay, J.2    Lemieux, P.3
  • 5
    • 0344178181 scopus 로고    scopus 로고
    • Modelling and simulation of chemotherapy of haematological and gynaecological cancers
    • F. K. Nani and M. N. Oguztereli, "Modelling and simulation of chemotherapy of haematological and gynaecological cancers," IMA J. Math. Appl. Med. Biol., vol. 16, pp. 39-91, 1999.
    • (1999) IMA J. Math. Appl. Med. Biol. , vol.16 , pp. 39-91
    • Nani, F.K.1    Oguztereli, M.N.2
  • 6
    • 0033933808 scopus 로고    scopus 로고
    • Optimizing drug resistance in cancer chemotherapy by an efficacy-toxicity mathematical model
    • A. Iliadis and D. Barbolosi, "Optimizing drug resistance in cancer chemotherapy by an efficacy-toxicity mathematical model," Comput. Biomed. Res,., vol. 33, pp. 211-226, 2000.
    • (2000) Comput. Biomed. Res. , vol.33 , pp. 211-226
    • Iliadis, A.1    Barbolosi, D.2
  • 7
    • 0035125321 scopus 로고    scopus 로고
    • Optimizing drug regimens in cancer chemotherapy: A simulation study using a PK-PD model
    • D. Barbolosi and A. Iliadis, "Optimizing drug regimens in cancer chemotherapy: A simulation study using a PK-PD model," Comput. Biol. Med.,, vol. 31, pp. 157-172, 2001.
    • (2001) Comput. Biol. Med. , vol.31 , pp. 157-172
    • Barbolosi, D.1    Iliadis, A.2
  • 8
    • 0034309182 scopus 로고    scopus 로고
    • Repopulation of tumour cells between cycles of chemotherapy: A neglected factor
    • J. Davis and I. F. Tannock, "Repopulation of tumour cells between cycles of chemotherapy: A neglected factor," The Lancet Oncol., vol. 1, pp. 86-93, 2000.
    • (2000) The Lancet Oncol. , vol.1 , pp. 86-93
    • Davis, J.1    Tannock, I.F.2
  • 9
    • 0036350193 scopus 로고    scopus 로고
    • Modeling multi-drug chemotherapy: Tailoring treatment to individuals
    • S. N. Gardner, "Modeling multi-drug chemotherapy: Tailoring treatment to individuals," J. Theor. Biol., vol. 214, pp. 181-207, 2002.
    • (2002) J. Theor. Biol. , vol.214 , pp. 181-207
    • Gardner, S.N.1
  • 10
    • 0037299744 scopus 로고    scopus 로고
    • Mathematical modeling of drug transport in tumour multicell spheroids and monolayer cultures
    • J. P. Ward and J. R. King, "Mathematical modeling of drug transport in tumour multicell spheroids and monolayer cultures," Mater. Biosci., vol. 181, pp. 177-207, 2003.
    • (2003) Mater. Biosci. , vol.181 , pp. 177-207
    • Ward, J.P.1    King, J.R.2
  • 11
    • 0035145085 scopus 로고    scopus 로고
    • Tracking tumor growth rates in patiens with malignant gliomas: A test of two algorithm
    • S.M. Haney, P.M. Thompson, T.F. Cloughesy, J.R. Alger, and A.W. Toga, "Tracking tumor growth rates in patiens with malignant gliomas: A test of two algorithm," Amr J. Neuroradiol., vol. 22, no. 1, pp. 73-82, 2001.
    • (2001) Amr J. Neuroradiol. , vol.22 , Issue.1 , pp. 73-82
    • Haney, S.M.1    Thompson, P.M.2    Cloughesy, T.F.3    Alger, J.R.4    Toga, A.W.5
  • 12
    • 0347252327 scopus 로고    scopus 로고
    • Automatic brain segmentation by subject specific modification of atlas priors
    • M. Prastawa, E. Bullitt, N. Moon, K. Leemput, and G. Gerig, "Automatic brain segmentation by subject specific modification of atlas priors," Acad. Radiol., vol. 10, no. 12, pp. 1341-8, 2003.
    • (2003) Acad. Radiol. , vol.10 , Issue.12 , pp. 1341-1348
    • Prastawa, M.1    Bullitt, E.2    Moon, N.3    Leemput, K.4    Gerig, G.5
  • 13
    • 0034696767 scopus 로고    scopus 로고
    • Simulated brain tumor growth dynamicsusing a three-dimensional cellular automaton
    • A. Kansal, S. Torquato, G. Harsh, E. Chiocca, and T. Deisboeck, "Simulated brain tumor growth dynamicsusing a three-dimensional cellular automaton," J. Theor. Biol., vol. 203, pp. 367-382, 2000.
    • (2000) J. Theor. Biol. , vol.203 , pp. 367-382
    • Kansal, A.1    Torquato, S.2    Harsh, G.3    Chiocca, E.4    Deisboeck, T.5
  • 14
    • 0242607878 scopus 로고    scopus 로고
    • Virtual and real brain tumors: Using mathematical modeling to quantify glioma growth and invasion
    • K. R. Swanson, C. Bridge, J. D. Murray, and E. C. Alvord, Jr, "Virtual and real brain tumors: Using mathematical modeling to quantify glioma growth and invasion," J. Neurol. Sci., vol. 216, pp. 1-10, 2003.
    • (2003) J. Neurol. Sci. , vol.216 , pp. 1-10
    • Swanson, K.R.1    Bridge, C.2    Murray, J.D.3    Alvord Jr., E.C.4
  • 15
    • 1042291055 scopus 로고    scopus 로고
    • Dynamics of a model for brain tumors reveals a small window for the therapeutic intervention
    • K. Swanson, E. C. Alvord, Jr., and J. D. Murray, "Dynamics of a model for brain tumors reveals a small window for the therapeutic intervention," Discrete Continuous Dynamical Syst.-Ser. B, vol. 4, no. 1, pp. 289-295, 2004.
    • (2004) Discrete Continuous Dynamical Syst.-Ser. B , vol.4 , Issue.1 , pp. 289-295
    • Swanson, K.1    Alvord Jr., E.C.2    Murray, J.D.3
  • 17
    • 0003539105 scopus 로고    scopus 로고
    • Perez and L. Brady, Eds., Philadelphia, PA: Lippincott-Raven
    • Perez and L. Brady, Eds., Principles and Practice of Radiation Oncology. Philadelphia, PA: Lippincott-Raven, 1998.
    • (1998) Principles and Practice of Radiation Oncology
  • 18
    • 1542287820 scopus 로고    scopus 로고
    • In silico radiation oncology: Combining novel simulation algorithms with current visualization techniques
    • S. Stamatakos, D. D. Dionysiou, E. I. Zacharaki, N. A. Mouravliansky, K. S. Nikita, and N. K. Uzunoglu, "In silico radiation oncology: Combining novel simulation algorithms with current visualization techniques," Proc. IEEE, vol. 90, no. 1, pp. 1764-1777, 2002.
    • (2002) Proc. IEEE , vol.90 , Issue.1 , pp. 1764-1777
    • Stamatakos, S.1    Dionysiou, D.D.2    Zacharaki, E.I.3    Mouravliansky, N.A.4    Nikita, K.S.5    Uzunoglu, N.K.6
  • 19
    • 0029134923 scopus 로고
    • Modeling of radiogenic responses induced by fractionated irradiation in malignant and normal tissue
    • W. Duechting, T. Ginsberg, and W. Ulmer, "Modeling of radiogenic responses induced by fractionated irradiation in malignant and normal tissue," Stem Cells, vol. 13, no. 1, pp. 301-306, 1995.
    • (1995) Stem Cells , vol.13 , Issue.1 , pp. 301-306
    • Duechting, W.1    Ginsberg, T.2    Ulmer, W.3
  • 20
    • 33746591944 scopus 로고    scopus 로고
    • G. Steel, Ed., London, U.K.: Arnold
    • G. Steel, Ed., Basic Clinical Radiobiology, 3rd ed. London, U.K.: Arnold, 2002, pp. 165-168, pp. 13, 52-63.
    • (2002) Basic Clinical Radiobiology, 3rd Ed. , pp. 165-168
  • 21
    • 13244297069 scopus 로고    scopus 로고
    • A mathematical model of doxorubicin treatment efficacy for non-Hodgkin's lymphoma: Investigation of the current protocol through theoretical modeling results
    • B. Ribba, K. Marron, Z. Agur, T. Alarcon, and P. K. Maini, "A mathematical model of doxorubicin treatment efficacy for non-Hodgkin's lymphoma: Investigation of the current protocol through theoretical modeling results," Bull. Math. Biol., vol. 67, pp. 79-99, 2005.
    • (2005) Bull. Math. Biol. , vol.67 , pp. 79-99
    • Ribba, B.1    Marron, K.2    Agur, Z.3    Alarcon, T.4    Maini, P.K.5
  • 22
    • 0034648765 scopus 로고    scopus 로고
    • Angiogenesis in cancer and other diseases
    • P. Carmeliet and R. K. Jain, "Angiogenesis in cancer and other diseases," Nature, vol. 407, pp. 249-259, 2002.
    • (2002) Nature , vol.407 , pp. 249-259
    • Carmeliet, P.1    Jain, R.K.2
  • 23
    • 0034660890 scopus 로고    scopus 로고
    • Fractals and cancer
    • W. Baish and R. F. Jain, "Fractals and cancer," Cancer Res., vol. 60, pp. 3683-3688, 2000.
    • (2000) Cancer Res. , vol.60 , pp. 3683-3688
    • Baish, W.1    Jain, R.F.2
  • 24
    • 0030614893 scopus 로고    scopus 로고
    • Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation
    • G. Helmlinger, F. Yuan, M. Dellian, and R. K. Jain, "Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation," Nature Med., vol. 3, pp. 177-182, 1997.
    • (1997) Nature Med. , vol.3 , pp. 177-182
    • Helmlinger, G.1    Yuan, F.2    Dellian, M.3    Jain, R.K.4
  • 27
    • 0031105962 scopus 로고    scopus 로고
    • Positive feedback and angiogenesis in tumor growth control
    • Michelson and J. T. Leith, "Positive feedback and angiogenesis in tumor growth control," Bull. Math. Biol,., vol. 59, no. 2, pp. 233-254, 1997.
    • (1997) Bull. Math. Biol,. , vol.59 , Issue.2 , pp. 233-254
    • Michelson1    Leith, J.T.2
  • 28
    • 0034005995 scopus 로고    scopus 로고
    • Temozolomide, a novel alkylating agent with activity in the central nervous system, may improve the treatment of advanced metastatic melanoma
    • S. Agarwala and J. Kirkwood, "Temozolomide, a novel alkylating agent with activity in the central nervous system, may improve the treatment of advanced metastatic melanoma," The Oncologist, vol. 5, pp. 144-151, 2000.
    • (2000) The Oncologist , vol.5 , pp. 144-151
    • Agarwala, S.1    Kirkwood, J.2
  • 29
    • 0030993717 scopus 로고    scopus 로고
    • Temozolomide: A review of its discovery, chemical properties, pre-clinical development and clinical trials
    • E. S. Newlands, M. F. Stevens, S. R. Wedge, R. T. Wheelhouse, and C. Brock, "Temozolomide: A review of its discovery, chemical properties, pre-clinical development and clinical trials," Cancer Treat. Rev., vol. 23, pp. 35-61, 1997.
    • (1997) Cancer Treat. Rev. , vol.23 , pp. 35-61
    • Newlands, E.S.1    Stevens, M.F.2    Wedge, S.R.3    Wheelhouse, R.T.4    Brock, C.5
  • 30
    • 0037818564 scopus 로고    scopus 로고
    • A review of its use in the treatment of malignant gliomas, malignant melanoma and other advanced cancers
    • M. J.M. Darkes, G. L. Plosker, B. Jarvis, and Temozolomide, "A review of its use in the treatment of malignant gliomas, malignant melanoma and other advanced cancers," Am. J. Cancer, vol. 1, no. 1, pp. 55-80, 2002.
    • (2002) Am. J. Cancer , vol.1 , Issue.1 , pp. 55-80
    • Darkes, M.J.M.1    Plosker, G.L.2    Jarvis, B.3    Temozolomide4
  • 33
    • 2342641211 scopus 로고    scopus 로고
    • Tumor growth and response to irradiation in vitro: A technologically advanced simulation model
    • G. Stamatakos, E. I. Zacharaki, N. K. Uzunoglu, and K. S. Nikita, "Tumor growth and response to irradiation in vitro: A technologically advanced simulation model," in Int. J. Radiat. Oncol. Biol. Phys., 2001, vol. 51, no. 1, pp. 240-241.
    • (2001) Int. J. Radiat. Oncol. Biol. Phys. , vol.51 , Issue.1 , pp. 240-241
    • Stamatakos, G.1    Zacharaki, E.I.2    Uzunoglu, N.K.3    Nikita, K.S.4
  • 37
    • 0003499531 scopus 로고    scopus 로고
    • M. C. Perry, Ed., Philadelphia, PA: Lippincott Williams and Wilkins
    • M. C. Perry, Ed., The Chemotherapy Source Book, 3rd ed. Philadelphia, PA: Lippincott Williams and Wilkins, 2001.
    • (2001) The Chemotherapy Source Book, 3rd Ed.
  • 40
    • 0036536697 scopus 로고    scopus 로고
    • Biochemical changes associated with a multidrug-resistant phenotype of a human glioma cell line with temozolomide-acquired resistance
    • J. Ma, M. Murphy, P. J. O'Dwyer, E. Berman, K. Reed, and J. M. Gallo, "Biochemical changes associated with a multidrug-resistant phenotype of a human glioma cell line with temozolomide-acquired resistance," Biochem. Pharmacol., vol. 63, pp. 1219-1228, 2002.
    • (2002) Biochem. Pharmacol. , vol.63 , pp. 1219-1228
    • Ma, J.1    Murphy, M.2    O'Dwyer, P.J.3    Berman, E.4    Reed, K.5    Gallo, J.M.6
  • 41
    • 0037217219 scopus 로고    scopus 로고
    • Temozolomide in combination with interferon alpha-2b in patients with metastatic melanoma: A phase I dose-escalation study
    • S. S. Agarwala and J. M. Kirkwood, "Temozolomide in combination with interferon alpha-2b in patients with metastatic melanoma: A phase I dose-escalation study," Cancer, vol. 97, pp. 121-127, 2003.
    • (2003) Cancer , vol.97 , pp. 121-127
    • Agarwala, S.S.1    Kirkwood, J.M.2
  • 42
    • 0037428798 scopus 로고    scopus 로고
    • Temozolomide induces apoptosis and senescence in glioma cells cultured as multicellular spheroids
    • W. Günther, E. Pawlak, R. Damasceno, H. Arnold, and A. J. Terzis, "Temozolomide induces apoptosis and senescence in glioma cells cultured as multicellular spheroids," Br. J. Cancer,., vol. 88, pp. 463-469, 2003.
    • (2003) Br. J. Cancer , vol.88 , pp. 463-469
    • Günther, W.1    Pawlak, E.2    Damasceno, R.3    Arnold, H.4    Terzis, A.J.5
  • 43
    • 0027007689 scopus 로고
    • O6-alkylguanine DNA-alkyltransferase is not a major determinant of sensitivity to 1,3-bis(2-chloroethyl)-1-nitrosourea in four medulloblastoma cell lines
    • J. R. Silber, M. S. Bobola, T. G. Ewers, M. Muramoto, and M. S. Berger, "O6-alkylguanine DNA-alkyltransferase is not a major determinant of sensitivity to 1,3-bis(2-chloroethyl)-1-nitrosourea in four medulloblastoma cell lines," Oncol. Res., vol. 4, pp. 241-248, 1992.
    • (1992) Oncol. Res. , vol.4 , pp. 241-248
    • Silber, J.R.1    Bobola, M.S.2    Ewers, T.G.3    Muramoto, M.4    Berger, M.S.5
  • 44
    • 0003257713 scopus 로고
    • A phase i study of SCH52365 (Temozolomide) in adult patients with advanced cancer
    • M. Brada, "A phase i study of SCH52365 (Temozolomide) in adult patients with advanced cancer," in Proc. Am. Soc. Clinical Oncology, 1995, vol. 14, no. 470.
    • (1995) Proc. Am. Soc. Clinical Oncology , vol.14 , Issue.470
    • Brada, M.1
  • 45
    • 0026513077 scopus 로고
    • Phase I Trial of Temozolomide CCRG 81045: M&B 39831:NSC 362856
    • E. S. Newlands, "Phase I Trial of Temozolomide (CCRG 81045: M&B 39831:NSC 362856," Br. J. Cancer, vol. 65, pp. 287-291, 1992.
    • (1992) Br. J. Cancer , vol.65 , pp. 287-291
    • Newlands, E.S.1
  • 46
    • 0003626981 scopus 로고    scopus 로고
    • Promising survival with concomitant and adjuvant temozolomide for newly diagnosed glioblastoma multiform
    • New Orleans, LA, May Abstract ASCO, 36th Ann. Mtg.
    • R. Stupp, "Promising survival with concomitant and adjuvant temozolomide for newly diagnosed glioblastoma multiform," in Proc. A. Soc. Clin. Oncol. New Orleans, LA, May 2000, 19, Abstract (632), 20-23, ASCO, 36th Ann. Mtg..
    • (2000) Proc. A. Soc. Clin. Oncol. , vol.19 , Issue.632 , pp. 20-23
    • Stupp, R.1
  • 47
    • 0035469483 scopus 로고    scopus 로고
    • Current and future developments in the use of temozolomide for the treatment of brain tumours
    • R. Stupp, M. Gander, S. Leyvraz, and E. Newlands, "Current and future developments in the use of temozolomide for the treatment of brain tumours," Lancet Oncol. Rev., vol. 2, no. 9, pp. 552-560, 2001.
    • (2001) Lancet Oncol. Rev. , vol.2 , Issue.9 , pp. 552-560
    • Stupp, R.1    Gander, M.2    Leyvraz, S.3    Newlands, E.4
  • 48
    • 33746612234 scopus 로고
    • Mathematical Methods in Pharmacokinetics. I Use of the Laplace Transform for Solving Differential Rate Equations
    • M. Mayersohn and M. Gibaldi, "Mathematical Methods in Pharmacokinetics. I Use of the Laplace Transform for Solving Differential Rate Equations," Am. J. Pharm., Education, vol. 34, pp. 608-614, 1970.
    • (1970) Am. J. Pharm., Education , vol.34 , pp. 608-614
    • Mayersohn, M.1    Gibaldi, M.2
  • 49
    • 12944253684 scopus 로고
    • Mathematical Methods in Pharmacokinetics II Solution of the Two Compartment Open Model
    • M. Mayersohn and M. Gibaldi, Amer. J. Pharm., Ed.
    • M. Mayersohn and M. Gibaldi, Amer. J. Pharm., Ed., "Mathematical Methods in Pharmacokinetics II Solution of the Two Compartment Open Model," Am. J. Pharm. Educ., vol. 35, pp. 19-28, 1971.
    • (1971) Am. J. Pharm. Educ. , vol.35 , pp. 19-28
  • 50
    • 0015318113 scopus 로고
    • General treatment of linear mammillary models with elimination from any compartment as used in pharmacokinetics
    • L. Z. Benet, "General treatment of linear mammillary models with elimination from any compartment as used in pharmacokinetics," J. Pharm. Sci., vol. 61, pp. 536-541, 1972.
    • (1972) J. Pharm. Sci. , vol.61 , pp. 536-541
    • Benet, L.Z.1
  • 51
    • 0035340512 scopus 로고    scopus 로고
    • Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy
    • O.L. Chinot, S. Honore, H. Dufour, M. Barrie, D. Figarella-Branger, X. Muracciole, D. Braguer, P. M. Martin, and F. Grisoli, "Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy," J. Clin. Oncol., vol. 19, no. 2, pp. 449-55, 2001.
    • (2001) J. Clin. Oncol. , vol.19 , Issue.2 , pp. 449-455
    • Chinot, O.L.1    Honore, S.2    Dufour, H.3    Barrie, M.4    Figarella-Branger, D.5    Muracciole, X.6    Braguer, D.7    Martin, P.M.8    Grisoli, F.9
  • 52
    • 0037010054 scopus 로고    scopus 로고
    • The treatment of brain metastases from malignant melanoma
    • J. G. Douglas and K. Margolin, "The treatment of brain metastases from malignant melanoma," Semin. Oncol., vol. 29, pp. 518-524, 2002.
    • (2002) Semin. Oncol. , vol.29 , pp. 518-524
    • Douglas, J.G.1    Margolin, K.2
  • 53
    • 0344211864 scopus 로고    scopus 로고
    • Use of temozolomide with other cytotoxic chemotherapy in the treatment of patients with recurrent brain metastases from lung cancer
    • B. L. Ebert, E. Niemierko, K. Shaffer, and R. Salgia, "Use of temozolomide with other cytotoxic chemotherapy in the treatment of patients with recurrent brain metastases from lung cancer," Oncologist, vol. 8, pp. 69-75, 2003.
    • (2003) Oncologist , vol.8 , pp. 69-75
    • Ebert, B.L.1    Niemierko, E.2    Shaffer, K.3    Salgia, R.4
  • 54
    • 0017342804 scopus 로고
    • Current status of population kinetics in gliomas
    • D. C. Crafts, T. Hoshino T, and Wilson CB, "Current status of population kinetics in gliomas," Bull. Cancer, vol. 64, pp. 115-124, 1977.
    • (1977) Bull. Cancer , vol.64 , pp. 115-124
    • Crafts, D.C.1    Hoshino T, T.2    Wilson, C.B.3
  • 56
    • 0015071439 scopus 로고
    • Pharmacodynamics of chemotherapeutic effects: Dose-time-response relationships for phase-nonspecific agents
    • W. J. Jusko, "Pharmacodynamics of chemotherapeutic effects: Dose-time-response relationships for phase-nonspecific agents," J. Pharm. Sci., vol. 60, no. 6, pp. 892-895, 1971.
    • (1971) J. Pharm. Sci. , vol.60 , Issue.6 , pp. 892-895
    • Jusko, W.J.1
  • 57
    • 0014889972 scopus 로고
    • Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedules
    • H. E. Skipper, F. M. Schabel, L. B. Mellett, J. A. Montgomery, L. J. Wilkoff, H. H. Lloyd, and R. W. Brockman, "Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedules," Cancer Chemother., vol. 54, pp. 431-450, 1970.
    • (1970) Cancer Chemother. , vol.54 , pp. 431-450
    • Skipper, H.E.1    Schabel, F.M.2    Mellett, L.B.3    Montgomery, J.A.4    Wilkoff, L.J.5    Lloyd, H.H.6    Brockman, R.W.7
  • 58
    • 0018957289 scopus 로고
    • Dependence of the cytostatic effect of adriamycin on drug concenration and exposure time in vitro
    • H. Eichholtz-Wirth, "Dependence of the cytostatic effect of adriamycin on drug concenration and exposure time in vitro," Br. J. Cancer, vol. 41, pp. 886-891, 1980.
    • (1980) Br. J. Cancer , vol.41 , pp. 886-891
    • Eichholtz-Wirth, H.1
  • 59
    • 0029657595 scopus 로고    scopus 로고
    • Role of O6-methylguanine-DNA methyltransferase in resistance of human brain tumor cell lines to the clinically relevant methylating agents temozolomide and streptozotocin
    • M. S. Bobola, S. H. Tseng, A. Blank, M. S. Berger, and J. R. Silber, "Role of O6-methylguanine-DNA methyltransferase in resistance of human brain tumor cell lines to the clinically relevant methylating agents temozolomide and streptozotocin," Clin. Cancer Res., vol. 2, pp. 735-741, 1996.
    • (1996) Clin. Cancer Res. , vol.2 , pp. 735-741
    • Bobola, M.S.1    Tseng, S.H.2    Blank, A.3    Berger, M.S.4    Silber, J.R.5
  • 60
    • 0028980765 scopus 로고
    • Contribution of O6-methylguanine-DNA methyltransferase to resistance to 1,3-(2-chloroethyl)-1-nitrosourea in human brain tumor-derived cell lines
    • M. S. Bobola, M. S. Berger, and J. R. Silber, "Contribution of O6-methylguanine-DNA methyltransferase to resistance to 1,3-(2-chloroethyl)-1- nitrosourea in human brain tumor-derived cell lines," Mol. Carcinog., vol. 13, pp. 81-88, 1995.
    • (1995) Mol. Carcinog. , vol.13 , pp. 81-88
    • Bobola, M.S.1    Berger, M.S.2    Silber, J.R.3
  • 61
    • 2342512813 scopus 로고    scopus 로고
    • A spatiotemporal simulation model of the response of solid tumors to radiotherapy in vivo: Parametric validation concerning oxygen enhancement ratio and cell cycle duration
    • V. Antipas, G. S. Stamatakos, N. Uzunoglu, D. Dionysiou, and R. Dale, "A spatiotemporal simulation model of the response of solid tumors to radiotherapy in vivo: Parametric validation concerning oxygen enhancement ratio and cell cycle duration," Phys. Med. Biol., vol. 49, pp. 1-20, 2004.
    • (2004) Phys. Med. Biol. , vol.49 , pp. 1-20
    • Antipas, V.1    Stamatakos, G.S.2    Uzunoglu, N.3    Dionysiou, D.4    Dale, R.5
  • 62
    • 0034851923 scopus 로고    scopus 로고
    • Tumor control probability modelling: Basic principles and applications in treatment planning
    • Nahum and B. Sanchez-Nieto, "Tumor control probability modelling: Basic principles and applications in treatment planning," Physica Medica, vol. 17, no. 2, pp. 13-23, 2001.
    • (2001) Physica Medica , vol.17 , Issue.2 , pp. 13-23
    • Nahum1    Sanchez-Nieto, B.2
  • 63
    • 0026703552 scopus 로고
    • Computer simulation and modeling of tumor spheroid growth and their relevance for optimization of fractionated radiotherapy
    • W. Duechting, W. Ulmer, R. Lehrig, T. Ginsberg, and E. Dedeleit, "Computer simulation and modeling of tumor spheroid growth and their relevance for optimization of fractionated radiotherapy," Strahlenther. Onkol., vol. 168, no. 6, pp. 354-360, 1992.
    • (1992) Strahlenther. Onkol. , vol.168 , Issue.6 , pp. 354-360
    • Duechting, W.1    Ulmer, W.2    Lehrig, R.3    Ginsberg, T.4    Dedeleit, E.5
  • 64
    • 0034309182 scopus 로고    scopus 로고
    • Repopulation of tumour cells between cycles of chemotherapy: A neglected factor
    • A. J. Davis and I. F. Tannock, "Repopulation of tumour cells between cycles of chemotherapy: A neglected factor," Lancet Oncol., vol. 1, pp. 86-93, 2000.
    • (2000) Lancet Oncol. , vol.1 , pp. 86-93
    • Davis, A.J.1    Tannock, I.F.2
  • 65
    • 0022205483 scopus 로고
    • Stem cell studies of human malignant brain tumours Part 2: Proliferation kinetics of brain-tumour cells in vitro in early-passage cultures
    • B. Pertuiset B. D. Dougherty, C. Cromeyer, T. Hoshino, M. Berger, and M.L.J. Rosenblum, "Stem cell studies of human malignant brain tumours Part 2: Proliferation kinetics of brain-tumour cells in vitro in early-passage cultures," Neurosurgery, vol. 63, no. 3, pp. 426-32, 1985.
    • (1985) Neurosurgery , vol.63 , Issue.3 , pp. 426-432
    • Pertuiset, B.1    Dougherty, B.D.2    Cromeyer, C.3    Hoshino, T.4    Berger, M.5    Rosenblum, M.L.J.6
  • 66
    • 3242707711 scopus 로고    scopus 로고
    • A Four dimensional in vivo model of tumour response to radiotherapy: Parametric validation considering radiosensitivity, genetic profile and fractionation
    • D.D. Dionysiou, G.S. Stamatakos, N.K. Uzunoglu, K.S. Nikita, and A. Marioli, "A Four dimensional in vivo model of tumour response to radiotherapy: Parametric validation considering radiosensitivity, genetic profile and fractionation," J. Theor. Biol., vol. 230, pp. 1-20, 2004.
    • (2004) J. Theor. Biol. , vol.230 , pp. 1-20
    • Dionysiou, D.D.1    Stamatakos, G.S.2    Uzunoglu, N.K.3    Nikita, K.S.4    Marioli, A.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.